Uss Investment Management LTD Biomarin Pharmaceutical Inc Transaction History

Uss Investment Management LTD

$12.3 Billion
Q2 2024

A detailed history of Uss Investment Management LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Uss Investment Management LTD holds 64,091 shares of BMRN stock, worth $4.48 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

64,091

Previous 61,005 5.06%

Holding current value

$4.48 Million

Previous $5.33 Million 0.98%

% of portfolio

0.04%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $229,690 - $284,590	3,086 Added 5.06%	64,091 $5.28 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $356,946 - $421,641	4,259 Added 7.51%	61,005 $5.33 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $413,798 - $534,810	-5,429 Reduced 8.73%	56,746 $5.47 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $827,731 - $919,290	9,730 Added 18.55%	62,175 $5.5 Million
Q3 2022 Nov 08, 2022	SELL	$82.16 - $96.94 $691,376 - $815,750	-8,415 Reduced 13.83%	52,445 $4.45 Million
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $188,778 - $229,370	-2,641 Reduced 4.16%	60,860 $5.05 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $1.22 Million - $1.52 Million	16,364 Added 34.72%	63,501 $4.9 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $43.1 Million - $49.2 Million	-576,049 Reduced 92.44%	47,137 $3.64 Million
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $254,135 - $315,700	3,500 Added 0.56%	623,186 $54.6 Million
Q2 2020 Aug 11, 2020	SELL	$79.55 - $124.22 $15.7 Million - $24.5 Million	-196,917 Reduced 24.11%	619,686 $76.4 Million
Q1 2020 May 11, 2020	SELL	$71.37 - $96.85 $25.8 Million - $35 Million	-361,859 Reduced 30.71%	816,603 $69 Million
Q4 2019 Feb 06, 2020	BUY	$64.27 - $86.37 $28.5 Million - $38.3 Million	443,462 Added 60.33%	1,178,462 $99.6 Million
Q4 2018 Jan 09, 2019	SELL	$80.14 - $106.07 $2.8 Million - $3.71 Million	-35,000 Reduced 4.55%	735,000 $62.7 Million
Q3 2018 Oct 23, 2018	SELL	$93.92 - $105.72 $31.9 Million - $35.9 Million	-340,000 Reduced 30.63%	770,000 $74.7 Million
Q2 2018 Jul 24, 2018	SELL	$76.01 - $99.03 $17.5 Million - $22.7 Million	-229,671 Reduced 17.14%	1,110,000 $105 Million
Q1 2018 May 09, 2018	BUY	$77.67 - $92.63 $19.4 Million - $23.1 Million	249,738 Added 22.91%	1,339,671 $112 Million
Q2 2017 Aug 08, 2017	BUY	N/A	1,089,933	1,089,933 $99 Million

Others Institutions Holding BMRN

# of Institutions

630

Shares Held

184M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.

Account

Uss Investment Management LTD Biomarin Pharmaceutical Inc Transaction History